Brave Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-5,724
Closed -$394K 156
2021
Q2
$394K Sell
5,724
-1,351
-19% -$93K 0.12% 89
2021
Q1
$457K Sell
7,075
-100
-1% -$6.46K 0.15% 72
2020
Q4
$418K Hold
7,175
0.16% 74
2020
Q3
$453K Hold
7,175
0.21% 58
2020
Q2
$552K Sell
7,175
-1,055
-13% -$81.2K 0.29% 47
2020
Q1
$615K Buy
8,230
+2,500
+44% +$187K 0.38% 45
2019
Q4
$372K Hold
5,730
0.19% 84
2019
Q3
$363K Buy
5,730
+500
+10% +$31.7K 0.21% 77
2019
Q2
$353K Buy
5,230
+1,850
+55% +$125K 0.2% 81
2019
Q1
$220K Buy
+3,380
New +$220K 0.12% 113
2018
Q4
Sell
-11,425
Closed -$882K 148
2018
Q3
$882K Sell
11,425
-350
-3% -$27K 0.45% 53
2018
Q2
$834K Sell
11,775
-2,499
-18% -$177K 0.48% 57
2018
Q1
$1.08M Sell
14,274
-3,320
-19% -$250K 0.65% 46
2017
Q4
$1.26M Sell
17,594
-7,682
-30% -$550K 0.66% 47
2017
Q3
$2.05M Buy
25,276
+19
+0.1% +$1.54K 1.07% 25
2017
Q2
$1.8M Sell
25,257
-5,364
-18% -$382K 0.96% 25
2017
Q1
$2.08M Sell
30,621
-2,778
-8% -$189K 1.22% 23
2016
Q4
$2.39M Buy
33,399
+77
+0.2% +$5.52K 1.53% 17
2016
Q3
$2.64M Buy
33,322
+4,575
+16% +$362K 1.69% 13
2016
Q2
$2.4M Buy
28,747
+2,562
+10% +$214K 1.6% 15
2016
Q1
$2.41M Buy
26,185
+1,755
+7% +$161K 1.69% 14
2015
Q4
$2.47M Buy
24,430
+150
+0.6% +$15.2K 1.67% 12
2015
Q3
$2.38M Buy
24,280
+5,255
+28% +$516K 1.82% 14
2015
Q2
$2.23M Buy
19,025
+500
+3% +$58.5K 1.56% 14
2015
Q1
$1.82M Buy
18,525
+8,720
+89% +$856K 1.27% 21
2014
Q4
$924K Buy
9,805
+4,755
+94% +$448K 0.66% 49
2014
Q3
$538K Hold
5,050
0.4% 76
2014
Q2
$419K Buy
5,050
+2,050
+68% +$170K 0.3% 96
2014
Q1
$213K Sell
3,000
-200
-6% -$14.2K 0.17% 110
2013
Q4
$240K Buy
+3,200
New +$240K 0.19% 101